Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 549 institutions that hold shares in the stock, with a total of 124 Million shares, which have been reported (via 13F filing form) to have a value of $8.01 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bernzott Capital Advisors
|
Jan 14, 2025 Q4 2024 |
93,985
shares
|
$6 Million
2.32% of portfolio
|
Q4 2024
New holding
|
|
|
Los Angeles Capital Management LLC
|
Feb 04, 2025 Q4 2024 |
92,475
shares
|
$5.9 Million
0.02% of portfolio
|
Q4 2024
Reduced 16.41%
|
|
|
Schroder Investment Management Group
London, X0 |
Feb 12, 2025 Q4 2024 |
87,503
shares
|
$5.59 Million
0.0% of portfolio
|
Q4 2024
Reduced 40.21%
|
|
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
Feb 14, 2025 Q4 2024 |
86,087
shares
|
$5.5 Million
0.01% of portfolio
|
Q4 2024
Added 4.71%
|
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
84,832
shares
|
$5.42 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
|
State Of Wisconsin Investment Board
Madison, WI |
Feb 14, 2025 Q4 2024 |
84,717
shares
|
$5.41 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.87%
|
|
|
Pdt Partners, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
84,062
shares
|
$5.37 Million
0.4% of portfolio
|
Q4 2024
Added 382.7%
|
|
|
Koa Wealth Management, LLC
Encinitas, CA |
Jan 23, 2025 Q4 2024 |
82,407
shares
|
$5.26 Million
3.22% of portfolio
|
Q4 2024
Added 10.64%
|
|
|
Colony Group LLC
Boston, MA |
Nov 14, 2023 Q3 2023 |
80,387
shares
|
$5.13 Million
0.05% of portfolio
|
Q3 2023
Added 0.01%
|
|
|
Readystate Asset Management LP
Chicago, IL |
Feb 14, 2025 Q4 2024 |
80,384
shares
|
$5.13 Million
0.12% of portfolio
|
Q4 2024
New holding
|
|
|
Synovus Financial Corp
Columbus, GA |
Feb 13, 2025 Q4 2024 |
78,600
shares
|
$5.02 Million
0.05% of portfolio
|
Q4 2024
Reduced 2.47%
|
|
|
Taylor Wealth Management Partners
Boston, MA |
Aug 12, 2022 Q2 2022 |
78,071
shares
|
$4.98 Million
1.95% of portfolio
|
Q2 2022
Reduced 5.24%
|
|
|
Shaker Investments LLC
|
Jan 29, 2025 Q4 2024 |
75,326
shares
|
$4.81 Million
1.55% of portfolio
|
Q4 2024
Added 12.3%
|
|
|
Hussman Strategic Advisors, Inc.
Ellicott City, MD |
Feb 03, 2025 Q4 2024 |
73,500
shares
|
$4.69 Million
1.1% of portfolio
|
Q4 2024
Added 75.0%
|
|
|
Truist Financial Corp
|
Jan 31, 2025 Q4 2024 |
73,158
shares
|
$4.67 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.76%
|
|
|
Lazard Asset Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
71,694
shares
|
$4.58 Million
0.01% of portfolio
|
Q4 2024
Reduced 67.06%
|
|
|
Comerica Bank
|
Feb 14, 2025 Q4 2024 |
71,105
shares
|
$4.54 Million
0.01% of portfolio
|
Q4 2024
Reduced 34.83%
|
|
|
Clari Vest Asset Management LLC
San Diego, CA |
Nov 12, 2024 Q3 2024 |
68,696
shares
|
$4.39 Million
0.39% of portfolio
|
Q2 2024
Added 0.21%
|
|
|
West Coast Financial LLC
|
Jan 14, 2025 Q4 2024 |
68,127
shares
|
$4.35 Million
0.36% of portfolio
|
Q4 2024
Reduced 5.56%
|
|
|
Guggenheim Capital LLC
Chicago, IL |
Feb 13, 2025 Q4 2024 |
65,949
shares
|
$4.21 Million
0.03% of portfolio
|
Q4 2024
Reduced 16.38%
|
|
|
Great Lakes Advisors, LLC
Chicago, IL |
Feb 07, 2025 Q4 2024 |
64,098
shares
|
$4.09 Million
0.03% of portfolio
|
Q4 2024
Reduced 22.15%
|
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
62,200
shares
|
$3.97 Million
0.81% of portfolio
|
Q3 2023
Reduced 34.87%
|
|
|
Clark Estates Inc
New York, NY |
Feb 06, 2025 Q4 2024 |
62,000
shares
|
$3.96 Million
0.79% of portfolio
|
Q4 2024
New holding
|
|
|
Brookstone Capital Management
|
Jan 13, 2025 Q4 2024 |
60,587
shares
|
$3.87 Million
0.05% of portfolio
|
Q3 2024
Reduced 1.8%
|
|
|
State Of Tennessee, Treasury Department
Nashville, TN |
Feb 13, 2025 Q4 2024 |
58,621
shares
|
$3.74 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.74%
|